Clinical Trial Update: Eight Week Primaquine Regimen for the Treatment of Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an eight-week primaquine regimen for vivax malaria has completed. The trial investigated extended primaquine therapy for treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Vivax Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Vivax Malaria | Phase 3 | Status: COMPLETED